Latest filing published 07 Jun 2007 for BIOMIMETIC THERAPEUTICS, INC., €81k.
Insider track record
No signal scores available.
Mark Barry Citron: trading record in brief
This profile gathers the share dealings of Mark Barry Citron in Biomimetic Therapeutics, Inc. Altogether 5 filings, all relating to 4 June 2007.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 7 June 2007, reports an option exercise of €81k in Biomimetic Therapeutics, Inc. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mark Barry Citron
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 82,500 shares@ US$1.33Common StockSEC:0001209191-07-035935:0
- 7,500 shares@ US$2.87Common StockSEC:0001209191-07-035935:1
- 7,500 shares@ US$3.47Common StockSEC:0001209191-07-035935:2
- 7,500 shares@ US$3.63Common StockSEC:0001209191-07-035935:3
- 3,750 shares@ US$3.63Common StockSEC:0001209191-07-035935:4
5 of 5 declarations